May 25, 2020
4DMedical's Lung Imaging Technology Receives FDA Clearance as COVID-19 Intensifies Global Focus on Respiratory Health
Jan 14, 2020
Rx Globally Patented Non-Steroidal Nasal Spray for All Lung Diseases including Pulmonary Fibrosis, CF, COPD, Unmet Needs with No Known Side Effects that can also be used to Deliver Antivirals, Antimicrobials, Insulin, and other Drugs
Dec 12, 2019
New Pulmonary Rehabilitation Program is a Breath of Fresh Air for Those With Chronic Lung Disease
Nov 07, 2019
PulmOne Now Offering FeNO by NIOX® with Its MiniBox+(TM) Complete Pulmonary Function Testing System
Oct 14, 2019
Identification of COPD, asthma and overlap syndrome can be teased out with spirometry following use of bronchodilator
Oct 01, 2019
Sosei Heptares Notes the Announcement of Positive Results from Phase III IRIDIUM Study of Inhaled Combination QVM149 in Patients with Uncontrolled Asthma
Jul 17, 2019
Respiratory Physiology - John B. West Lecture Series Launched by UC San Diego School of Medicine and MediPines
May 30, 2019
Pulmonary Fibrosis Patient Registry Research Presented At American Thoracic Society Conference
May 20, 2019
Phase III study showed Ofev® slows the loss of pulmonary function in people living with systemic sclerosis associated ILD
May 20, 2019
Theravance Biopharma and Mylan Present Additional YUPELRI® (revefenacin) Phase 3 Data Analysis at the 2019 ATS International Conference
Nov 09, 2018
Theravance Biopharma and Mylan Receive FDA Approval for YUPELRI(TM) (revefenacin) in Adults with Chronic Obstructive Pulmonary Disease
Oct 04, 2018
Triple dual therapy significantly improves lung function, quality of life in COPD patients
Sep 18, 2018
RejuvenAir® Metered Cryospray(TM) Shows Promise as Treatment for COPD Patients with Chronic Bronchitis
Sep 17, 2018
Theravance Biopharma and Mylan Report New Data from Phase 3 Studies of YUPELRI(TM) (revefenacin) in Oral Presentation at the European Respiratory Society International Congress
Sep 17, 2018
Gala Presents Positive Results from First-In-Human Clinical Trial of RheOx(TM) in Chronic Bronchitis at the European Respiratory Society
Aug 08, 2018
Landmark Pulmonary Clinical Study Published in Respiratory Therapy
Jul 31, 2018
Spirometer Market Size Worth $1.3 Billion by 2025 | CAGR: 9.4%: Grand View Research, Inc.
Jun 20, 2018
Significant reductions in costly pulmonary complications with use of drug-free device
Jun 13, 2018
Pulmatrix Announces Publication of Results from a Phase 1 Pharmacodynamic Study of PUR0200 in COPD Patients
Jun 07, 2018
Henry Schein Medical Launches Its New EasyOne Air Spirometer